ENDECE

endece-logo

Endece is a privately held biopharmaceutical company at the forefront of new discovery and development. Our library of proprietary compounds, invented and owned by ENDECE, was designed to stop disease by regulating specific biological pathways to stimulate a biological response for a gain of function. we focus on diseases whose treatment options are limited or non-existent, whose causes may not be well understood and whose clinical development paths are still undefined including multiple sclerosis (MS) and Alzheimer's disease.

#SimilarOrganizations #People #Website #More

ENDECE

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2006-01-01

Address:
Mequon, Wisconsin, United States

Country:
United States

Website Url:
http://www.endece.com

Total Employee:
1+

Status:
Active

Contact:
+1 262-240-9690

Total Funding:
7.44 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics


Similar Organizations

critical-therapeuticsinc-logo

Critical Therapeutics,Inc.

Critical Therapeutics, Inc. is a privately held biopharmaceutical company focused on critical care medicine.

epix-pharmaceuticals-logo

Epix Pharmaceuticals

EPIX Pharmaceuticals is a biopharmaceutical company engaging in the discovery and development of therapeutics.

Current Employees Featured

jean-yarger_image

Jean Yarger
Jean Yarger Chief Administrative Officer @ Endece
Chief Administrative Officer

james-yarger_image

James Yarger
James Yarger Founder and CEO @ Endece
Founder and CEO

Founder


james-yarger_image

James Yarger

jean-yarger_image

Jean Yarger

Official Site Inspections

http://www.endece.com

  • Host name: 242.45.167.72.host.secureserver.net
  • IP address: 72.167.45.242
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Endece"

Endece - Crunchbase Company Profile & Funding

Endece is a privately held biopharmaceutical company at the forefront of new discovery and development. Our library of proprietary compounds, invented and owned by ENDECE, was designed to stop disease by regulating specific …See details»

ENDECE NDC-1308 the promise of treating neurodegenerative …

NDC-1308. NDC-1308 has a unique mechanism-of-action for inducing remyelination AND inhibiting demyelination which differentiates NDC-1308 from ALL other Multiple Sclerosis drugs.See details»

ENDECE Company Profile 2024: Valuation, Funding

ENDECE General Information Description. Operator of a drug development company intended to focus on first-in-class therapeutics for cancer. The company focuses on small-molecule compounds that control key genes within specific …See details»

Endece - Overview, News & Competitors | ZoomInfo.com

ENDECE is fully committed to creating a healthier future and is proud to serve our community, country and the world. Read More. View Company Info for Free. Who is Endece. …See details»

The ENDECE Management Team of experienced Neuroscience …

ENDECE products are built on a very strong foundation of exciting science and will be well positioned for both launch success and life cycle management across appropriate indications …See details»

Endece,Llc: Contact Details and Business Profile - RocketReach

ENDECE, LLC (ENDECE), founded in 2006, is a privately held biopharmaceutical drug discovery and development company with offices in Mequon, Wisconsin and San Francisco, California. …See details»

Contact - ENDECE

ENDECE, LLC. Corporate Office: Portland, Oregon Office: (503) 536-2639 [email protected]See details»

Endece - Contacts, Employees, Board Members, Advisors

Endece is a privately held bio-pharmaceutical company at the forefront of new discovery and development.See details»

Endece - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 20, 2011: Funding Round - …See details»

Endece LLC - Drug pipelines, Patents, Clinical trials - Synapse

Explore Endece LLC with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Hemic and Lymphatic Diseases, Nervous System Diseases, …See details»

Endece's Leadership Team Team - Team members and org chart

Other teams at Endece. View all. CEO and Executive Team. 3 members. Board of Directors. 1 members. The Org helps you hire great candidates. It takes less than ten minutes to set up …See details»

ENDECE, LLC - WEDC

ENDECE, LLC 1001 W. Glen Oaks Lane, Suite 105B Mequon, WI 53092 https://www.endece.com. ENDECE is focused on discovery and development of new drug …See details»

Endece, LLC Company Profile | Portland, OR - Dun & Bradstreet

Added by Endece, LLC. This information is updated and provided by Endece, LLC. The content available on the D&B Business Directory is provided "as-is" and "as-available" and may not be …See details»

Endece Company Profile | Management and Employees List

Find contact information for Endece. Learn about their Manufacturing market share, competitors, and Endece's email format.See details»

Endece - Crunchbase

Endece is a privately held bio-pharmaceutical company at the forefront of new discovery and development.See details»

Endece,Llc Management Team | Org Chart - RocketReach

Endece,Llc employs 6 employees. The Endece,Llc management team includes James Yarger (Chief Executive Officer and Co-Founder), and Jean Yarger (Cheif Administrative Officer). Get …See details»

Endece, LLC Company Profile | San Francisco, CA | Competitors ...

Endece, LLC. D&B Business Directory HOME / BUSINESS DIRECTORY / PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES / SCIENTIFIC RESEARCH AND …See details»

Discovery - ENDECE

ENDECE developed lead drug NDC-1308 with a dual Mechanism of Action (MOA) providing an anti-inflammatory environment and induces remyelination within the Central Nervous System, …See details»

James Yarger - CEO and Co-founder @ Endece - Crunchbase

Primary Organization . Endece . Location Portland, Oregon, United States; Regions West Coast, Western US; Gender Male; LinkedIn View on LinkedIn ; James Yarger is the CEO and co …See details»

News - ENDECE

ENDECE developed lead drug NDC-1308 with a dual Mechanism of Action (MOA) providing an anti-inflammatory environment and induces remyelination within the Central Nervous System, …See details»

linkstock.net © 2022. All rights reserved